Bivatuzumab

(Synonyms: BIWA 4; Anti-CD44 Recombinant Antibody)
Kundenbewertung

Based on 1 Customer Validation

Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.82%
  • CAS. Nr.: 214559-60-1
  • Molecular Weight:143.22 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00